Terms: = Skin cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Treatment
18 results:
1. Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma.
Mo Z; Liu J; Zhang J; Deng Y; Xu M; Jiang Y
Int Immunopharmacol; 2023 Nov; 124(Pt B):110973. PubMed ID: 37769536
[TBL] [Abstract] [Full Text] [Related]
2. Comparative safety of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced anaplastic lymphoma kinase-mutated non-small cell lung cancer: Systematic review and network meta-analysis.
Luo Y; Zhang Z; Guo X; Tang X; Li S; Gong G; Gao S; Zhang Y; Lin S
Lung Cancer; 2023 Oct; 184():107319. PubMed ID: 37597303
[TBL] [Abstract] [Full Text] [Related]
3. Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Raimondi A; Randon G; Prisciandaro M; Pagani F; Lonardi S; Antoniotti C; Bozzarelli S; Sartore-Bianchi A; Tampellini M; Fanchini L; Murialdo R; Clavarezza M; Zaniboni A; Berenato R; Ratti M; Petrelli F; Antonuzzo L; Giordano M; Rossi A; Di Bartolomeo M; Di Maio M; Pietrantonio F; Morano F
Int J Cancer; 2022 Nov; 151(10):1760-1769. PubMed ID: 35678328
[TBL] [Abstract] [Full Text] [Related]
4. Cost-Effectiveness of Pembrolizumab Versus Carboplatin and Paclitaxel in Patients With Unresectable or Metastatic Melanoma After First-Line treatment in China.
Tang WX; Shao RJ; Wang J; Scherrer E; Ma AX; Aguiar-Ibáñez R
Value Health Reg Issues; 2022; 27():99-107. PubMed ID: 34922053
[TBL] [Abstract] [Full Text] [Related]
5. Symptom status, body perception, and risk of anxiety and depression in breast cancer patients receiving paclitaxel: a prospective longitudinal study.
Gokce Ceylan G; Gok Metin Z
Support Care Cancer; 2022 Mar; 30(3):2069-2079. PubMed ID: 34657181
[TBL] [Abstract] [Full Text] [Related]
6. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
Porto AC; Pinto Blumetti T; Oliveira Santos Filho IDA; Calsavara VF; Duprat Neto JP; Tavoloni Braga JC
PLoS One; 2020; 15(10):e0240864. PubMed ID: 33095773
[TBL] [Abstract] [Full Text] [Related]
7. Management experience of advanced-stage mycosis fungoides/Sézary syndrome: a retrospective study from Spanish haematology referral units.
Novelli S; Martín A; Sánchez JJ; Espeso M; Mozos A; Briones J
Eur J Dermatol; 2020 Aug; 30(4):397-403. PubMed ID: 32815814
[TBL] [Abstract] [Full Text] [Related]
8. Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases.
Bowden GN; Kim JO; Faramand A; Fallon K; Flickinger J; Lunsford LD
J Neurosurg; 2020 May; 134(5):1430-1434. PubMed ID: 32384280
[TBL] [Abstract] [Full Text] [Related]
9. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?
Huis In 't Veld EA; van Coevorden F; Grünhagen DJ; Smith MJ; van Akkooi ACJ; Wouters MWJM; Hayes AJ; Verhoef C; Strauss DC; van Houdt WJ
Cancer; 2019 Mar; 125(5):735-741. PubMed ID: 30644528
[TBL] [Abstract] [Full Text] [Related]
10. Are patients satisfied with the head and neck skin cancer service? An evaluation of outpatient services with a review of published reports.
Petrosyan V; Patel K; Ameerally PJ
Br J Oral Maxillofac Surg; 2017 Dec; 55(10):1018-1023. PubMed ID: 29169670
[TBL] [Abstract] [Full Text] [Related]
11. Suboptimal Compliance With National Comprehensive cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract] [Full Text] [Related]
12. Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.
Xu RH; Li J; Bai Y; Xu J; Liu T; Shen L; Wang L; Pan H; Cao J; Zhang D; Fan S; Hua Y; Su W
J Hematol Oncol; 2017 Jan; 10(1):22. PubMed ID: 28103904
[TBL] [Abstract] [Full Text] [Related]
13. Effectiveness, toxicity, and economic evaluation of ipilimumab for the treatment of patients with metastatic melanoma in the Spanish outpatient setting.
Guglieri-López B; Pérez-Pitarch A; Porta Oltra B; Ferriols-Lisart F; Royo-Peiró Á; Climente-Martí M
Anticancer Drugs; 2016 Aug; 27(7):679-84. PubMed ID: 27058705
[TBL] [Abstract] [Full Text] [Related]
14. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract] [Full Text] [Related]
15. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
[TBL] [Abstract] [Full Text] [Related]
16. Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter.
Gaitanis G; Bassukas ID
Acta Derm Venereol; 2014 Jan; 94(1):38-44. PubMed ID: 23722308
[TBL] [Abstract] [Full Text] [Related]
17. Chronic arsenic toxicity in Bangladesh and West Bengal, India--a review and commentary.
Rahman MM; Chowdhury UK; Mukherjee SC; Mondal BK; Paul K; Lodh D; Biswas BK; Chanda CR; Basu GK; Saha KC; Roy S; Das R; Palit SK; Quamruzzaman Q; Chakraborti D
J Toxicol Clin Toxicol; 2001; 39(7):683-700. PubMed ID: 11778666
[TBL] [Abstract] [Full Text] [Related]
18. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract] [Full Text] [Related]
